{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:16:51Z","timestamp":1787984211000,"version":"build-2784847793"},"reference-count":34,"publisher":"Medical Association of Nippon Medical School","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2026,8,20]]},"DOI":"10.1272\/jnms.jnms.2026_93-407","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:13:33Z","timestamp":1787609613000},"page":"297-303","source":"Crossref","is-referenced-by-count":0,"title":["Late-Onset Hypogonadism in Male Hemodialysis Patients: Association with Statin Therapy and Cholesterol Levels"],"prefix":"10.1272","volume":"93","author":[{"given":"Hiroyuki","family":"Fujinami","sequence":"first","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Oita University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadasuke","family":"Ando","sequence":"additional","affiliation":[{"name":"Organ Transplant Promotion Project, Faculty of Medicine, Oita University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhito","family":"Shibahara","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Oita University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Fujita","sequence":"additional","affiliation":[{"name":"Hemodialysis Center, Nankai Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Oita University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ide H, Akehi Y, Fukuhara S, et al. Summary of the clinical practice manual for late-onset hypogonadism. Int J Urol. 2023 May;30 (5):422\u201330.","DOI":"10.1111\/iju.15160"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nieschlag E. Late-onset hypogonadism: a concept comes of age. Andrology. 2020 Nov;8 (6):1506\u201311.","DOI":"10.1111\/andr.12719"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Braga PC, Pereira SC, Ribeiro JC, et al. Late-onset hypogonadism and lifestyle-related metabolic disorders. Andrology. 2020 Nov;8 (6):1530\u20138.","DOI":"10.1111\/andr.12765"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Corona G, Krausz C. Late-onset hypogonadism: a challenging task for the andrology field. Andrology. 2020 Nov;8 (6):1504\u20135.","DOI":"10.1111\/andr.12917"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jaschke N, Wang A, Hofbauer LC, Rauner M, Rachner TD. Late-onset hypogonadism: clinical evidence, biological aspects and evolutionary considerations. Ageing Res Rev. 2021 May;67:101301.","DOI":"10.1016\/j.arr.2021.101301"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kam SC, Shin YS. Novel therapeutic approach for late-onset hypogonadism. World J Mens Health. 2024 Jul;42 (3):658\u20139.","DOI":"10.5534\/wjmh.240011"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cannarella R, Marino M, Crafa A, et al. Impact of COVID-19 on testicular function: a systematic review and meta-analysis. Endocrine. 2024 Jul;85 (1):44\u201366.","DOI":"10.1007\/s12020-024-03705-7"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lanser L, Burkert FR, Thommes L, et al. Testosterone deficiency is a risk factor for severe COVID-19. Front Endocrinol (Lausanne). 2021 Jun;12:694083.","DOI":"10.3389\/fendo.2021.694083"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yamamoto Y, Otsuka Y, Sunada N, et al. Detection of male hypogonadism in patients with post COVID-19 condition. J Clin Med. 2022 Mar;11 (7):1955.","DOI":"10.3390\/jcm11071955"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kikuchi K, Nangaku M, Ryuzaki M, et al. Effectiveness of SARS-CoV-2 vaccines on hemodialysis patients in Japan: a nationwide cohort study. Ther Apher Dial. 2023 Feb;27 (1):19\u201323.","DOI":"10.1111\/1744-9987.13887"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sugawara Y, Iwagami M, Kikuchi K, et al. Coronavirus disease 2019 vaccination effectiveness based on the 2021 Japanese dialysis registry. Nephrology (Carlton). 2024 Oct;29 (10):671\u20139.","DOI":"10.1111\/nep.14366"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wu HC, Lee LC, Wang WJ. The association between serum testosterone and mortality among elderly men on hemodialysis. J Clin Lab Anal. 2018 Jun;32 (5):e22394.","DOI":"10.1002\/jcla.22394"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakashima A, Ohkido I, Yokoyama K, Mafune A, Urashima M, Yokoo T. Associations between low serum testosterone and all-cause mortality and infection-related hospitalization in male hemodialysis patients: a prospective cohort study. Kidney Int Rep. 2017 Aug;2 (6):1160\u20138.","DOI":"10.1016\/j.ekir.2017.07.015"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Inoue Y, Nakamura K, Kuwahara Y, et al. Efficacy of testosterone treatment in hemodialysis patients as assessed by Aging Males&apos; Symptoms scores: a pilot study. Am J Mens Health. 2018 Sep;12 (5):1541\u20137.","DOI":"10.1177\/1557988318772734"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Li L, Ju H, Jin H, Chen H, Sun M, Zhou Z. Low testosterone level and risk of adverse clinical events among male patients with chronic kidney disease: a systematic review and meta-analysis of cohort studies. J Healthc Eng. 2022 Sep;2022:3630429.","DOI":"10.1155\/2022\/3630429"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Romejko K, Rymarz A, Sadownik H, Niemczyk S. Testosterone deficiency as one of the major endocrine disorders in chronic kidney disease. Nutrients. 2022 Aug;14 (16):3438.","DOI":"10.3390\/nu14163438"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Skiba R, Rymarz A, Matyjek A, et al. Testosterone replacement therapy in chronic kidney disease patients. Nutrients. 2022 Aug;14 (16):3444.","DOI":"10.3390\/nu14163444"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ando T, Kamegawa T, Shin T, Mimata H. Lower urinary tract symptoms impair the quality of life in maintenance hemodialysis patients. Ren Replace Ther. 2019 Dec;5 (1):35.","DOI":"10.1186\/s41100-019-0230-y"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Schmidt A, Luger A, Horl WH. Sexual hormone abnormalities in male patients with renal failure. Nephrol Dial Transplant. 2002 Mar;17 (3):368\u201371.","DOI":"10.1093\/ndt\/17.3.368"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Turner HE, Wass JA. Gonadal function in men with chronic illness. Clin Endocrinol (Oxf). 1997 Oct;47 (4):379\u2013403.","DOI":"10.1046\/j.1365-2265.1997.2611108.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kuczera P, Adamczak M, Wiecek A. Changes of serum total and free testosterone concentrations in male chronic hemodialysis patients with secondary hyperparathyroidism in response to cinacalcet treatment. Kidney Blood Press Res. 2016 Jan;41 (1):1\u20138.","DOI":"10.1159\/000368541"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. DeLong M, Logan JL, Yong KC, Lien YH. Renin-angiotensin blockade reduces serum free testosterone in middle-aged men on haemodialysis and correlates with erythropoietin resistance. Nephrol Dial Transplant. 2005 Mar;20 (3):585\u201390.","DOI":"10.1093\/ndt\/gfh638"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Corona G, Boddi V, Balercia G, et al. The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction. J Sex Med. 2010 Apr;7 (4 Pt 1):1547\u201356.","DOI":"10.1111\/j.1743-6109.2009.01698.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Azzarito C, Boiardi L, Vergoni W, Zini M, Portioli I. Testicular function in hypercholesterolemic male patients during prolonged simvastatin treatment. Horm Metab Res. 1996 Apr;28 (4):193\u20138.","DOI":"10.1055\/s-2007-979159"},{"key":"25","unstructured":"25. Dohle GR, Arver S, Bettocchi C, Jones TH, Kliesch S. EAU guidelines on male hypogonadism [Internet]. Arnhem: European Association of Urology; 2019. [cited 2020 Jul 30]. Available from: https:\/\/uroweb.org\/guideline\/male-hypogonadism"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kanda Y. Investigation of the freely available easy-to-use software &apos;EZR&apos; for medical statistics. Bone Marrow Transplant. 2013 Mar;48 (3):452\u20138.","DOI":"10.1038\/bmt.2012.244"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Fellstrom BC, Holdaas H, Jardine AG. Why do we need a statin trial in hemodialysis patients? Kidney Int Suppl. 2003 May;63 Suppl 84:S204\u20136.","DOI":"10.1046\/j.1523-1755.63.s84.10.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2019 Jun;73 (24):3168\u2013209.","DOI":"10.1016\/j.jacc.2018.11.004"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Fellstrom BC, Jardine AG, Schmieder RE, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009 Apr;360 (14):1395\u2013407.","DOI":"10.1056\/NEJMoa0810177"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hou W, Lv J, Perkovic V, et al. Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. Eur Heart J. 2013 Jun;34 (24):1807\u201317.","DOI":"10.1093\/eurheartj\/eht065"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Thobani A, Jacobson TA. Dyslipidemia in patients with kidney disease. Cardiol Clin. 2021 Aug;39 (3):353\u201363.","DOI":"10.1016\/j.ccl.2021.04.008"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Wanner C, Tonelli M; Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members. KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney Int. 2014 Jun;85 (6):1303\u20139.","DOI":"10.1038\/ki.2014.31"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wanner C, Krane V, Marz W, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005 Jul;353 (3):238\u201348.","DOI":"10.1056\/NEJMoa043545"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kavousi M, Leening MJ, Nanchen D, et al. Comparison of application of the ACC\/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA. 2014 Apr;311 (14):1416\u201323.","DOI":"10.1001\/jama.2014.2632"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/4\/93_JNMS.2026_93-407\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:29:39Z","timestamp":1787981379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/4\/93_JNMS.2026_93-407\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2026_93-407","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"article-number":"JNMS.2026_93-407"}}